Zhao Yan

Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.

Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.

Journal: Human cell
Published: August 06, 2024

Recent Advances of Organic-Inorganic Hybrid Fluorescent Hyperbranched Polymer: Synthesis, Performance Regulation Strategies and Applications.

Recent Advances of Organic-Inorganic Hybrid Fluorescent Hyperbranched Polymer: Synthesis, Performance Regulation Strategies and Applications.

Journal: ChemPlusChem
Published: April 29, 2024

Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.

Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.

Journal: Stem cell research & therapy
Published: September 29, 2023

RNA-binding Protein QKI Inhibits Osteogenic Differentiation Via Suppressing Wnt Pathway.

RNA-binding Protein QKI Inhibits Osteogenic Differentiation Via Suppressing Wnt Pathway.

Journal: Archives of medical research
Published: January 25, 2023

QKI degradation in macrophage by RNF6 protects mice from MRSA infection via enhancing PI3K p110β dependent autophagy.

QKI degradation in macrophage by RNF6 protects mice from MRSA infection via enhancing PI3K p110β dependent autophagy.

Journal: Cell & bioscience
Published: February 11, 2022

Association between the inclination angle of the proximal tibiofibular joint surface and medial compartment knee osteoarthritis.

Association between the inclination angle of the proximal tibiofibular joint surface and medial compartment knee osteoarthritis.

Journal: Annals of palliative medicine
Published: May 14, 2021

QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism.

QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism.

Journal: Cell death & disease
Published: November 25, 2019

MOTS-c inhibits Osteolysis in the Mouse Calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation.

MOTS-c inhibits Osteolysis in the Mouse Calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation.

Journal: Pharmacological research
Published: April 03, 2019

Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells.

Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells.

Journal: Frontiers in pharmacology
Published: February 03, 2019

RNA-binding protein QKI regulates contact inhibition via Yes-associate protein in ccRCC.

RNA-binding protein QKI regulates contact inhibition via Yes-associate protein in ccRCC.

Journal: Acta biochimica et biophysica Sinica
Published: June 21, 2018

Metformin suppresses UHMWPE particle-induced osteolysis in the mouse calvaria by promoting polarization of macrophages to an anti-inflammatory phenotype.

Metformin suppresses UHMWPE particle-induced osteolysis in the mouse calvaria by promoting polarization of macrophages to an anti-inflammatory phenotype.

Journal: Molecular medicine (Cambridge, Mass.)
Published: January 10, 2018

Metformin protects bone mass in ultra-high-molecular-weight polyethylene particle-induced osteolysis by regulating osteocyte secretion.

Metformin protects bone mass in ultra-high-molecular-weight polyethylene particle-induced osteolysis by regulating osteocyte secretion.

Journal: Journal of bone and mineral metabolism
Published: November 09, 2017
Showing 1-12 of 14

Last Updated: 09/26/2026